BPC-157 is a 15-amino-acid synthetic peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, derived from a partial sequence of human gastric juice protein

Our findings raise the possibility of using PEPITEM derived peptides for the treatment of psoriasis." "This study also raises the interesting possibility that PEPITEM derived peptides could be used in combination with other psoriasis therapies, allowing lower dosing for longer durations, for example, a 'steroid sparing' approach, to reduce the side effects associated with prolonged use of such agents." Further investigation showed both the whole PEPITEM molecule and the tripeptide sequences are powerful regulators for the synthesis of signalling molecules that promote inflammation, leading to the recruitment of immune cells and proliferation of other cell types in skin tissue involved in disease, with some tripeptide sequences showing an order of magnitude increase in efficacy compared to the parent PEPITEM sequence
full result over 23 cycles (roughly 46 months )
No universal dose: appropriate use depends on an individuals health profile and is determined by a licensed provider, not a standard number from the internet
Candidacy and Contraindications MIC is generally well tolerated
For ongoing safety, keep your healthcare provider informed about how youre feeling during the therapy